Budapest, Hungary

Margit Biblo

This inventor holds 1 USPTO granted patent. Top assignee: Biogal Gyogyszergyar Rt.. Active years: 1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Margit Biblo. Retrieved from https://idiyas.com/inventor/margit-biblo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Margit Biblo: Innovator in Pharmaceutical Composition

Introduction

Margit Biblo is a notable inventor based in Budapest, Hungary. She has made significant contributions to the field of pharmaceuticals, particularly in the preparation of tablet and dragee compositions.

Latest Patents

Margit holds a patent for a "Process for the preparation of a tablet or dragee composition containing." This innovation showcases her expertise in developing effective pharmaceutical formulations. She has 1 patent to her name.

Career Highlights

Margit is currently employed at Biogal Gyogyszergyar Rt., a company known for its commitment to pharmaceutical advancements. Her work at Biogal has allowed her to focus on innovative solutions in drug formulation.

Collaborations

Margit has collaborated with esteemed colleagues, including Istvan Kovacs and Katalin Beke. These partnerships have further enriched her research and development efforts in the pharmaceutical industry.

Conclusion

Margit Biblo's contributions to pharmaceutical innovation highlight her role as a key figure in the industry. Her patent and collaborations reflect her dedication to advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…